GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Debt-to-EBITDA

Ventana Biotech (Ventana Biotech) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2008. Start your Free Trial

What is Ventana Biotech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ventana Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Ventana Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Ventana Biotech's annualized EBITDA for the quarter that ended in . 20 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ventana Biotech's Debt-to-EBITDA or its related term are showing as below:

VNTA's Debt-to-EBITDA is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.95
* Ranked among companies with meaningful Debt-to-EBITDA only.

Ventana Biotech Debt-to-EBITDA Historical Data

The historical data trend for Ventana Biotech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventana Biotech Debt-to-EBITDA Chart

Ventana Biotech Annual Data
Trend
Debt-to-EBITDA

Ventana Biotech Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of Ventana Biotech's Debt-to-EBITDA

For the Shell Companies subindustry, Ventana Biotech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ventana Biotech's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Ventana Biotech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ventana Biotech's Debt-to-EBITDA falls into.



Ventana Biotech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ventana Biotech's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Ventana Biotech's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


Ventana Biotech  (OTCPK:VNTA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ventana Biotech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ventana Biotech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ventana Biotech (Ventana Biotech) Business Description

Traded in Other Exchanges
N/A
Address
1660 South Albion Street, Suite 1007, Denver, CO, USA, 80222
Ventana Biotech Inc is a development stage company providing alternative financing in the capacity of a broker for those commercial borrowers in need of non-bank financing.